Ramucirumab in Squamous Non-Small Cell Lung Cancer

3 Views
administrator
administrator
07/14/23

The panelists, Benjamin Levy, MD; Edward S. Kim, MD, FACP; and Paul K. Paik, MD, assess clinical trial results of monoclonal antibody, ramucirumab, and its role in squamous non-small cell lung cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next